Chris Lloyd is a Senior Scientist working in the Antibody Discovery and Protein Engineering (ADPE) group at MedImmune, Cambridge UK. He has over 15 years’ experience in the field of antibody engineering at MedImmune (and previously CAT), currently with an active interest in bispecific antibodies and ADCs. He is responsible for leading early-stage research projects across multiple therapy areas, including oncology, neuroscience and metabolic disease. He also leads a cross-functional R&D team to devise strategies for understanding and engineering biotherapeutics with good developability profiles.
Conference 29 - 31 October • Exhibition & Seminars 29 - 31 October
To sponsor or exhibit contact:
Derek Cavanagh
+44 (0)207 092 1297
derek.cavanagh@terrapinn.com
To speak:
Joan Shutt
+44 (0)207 092 1134
joan.shutt@terrapinn.com